Your browser doesn't support javascript.
loading
Liver safety evaluation of endothelin receptor antagonists using HepatoPac® : A single model impact assessment on hepatocellular health, function and bile acid disposition.
Aleo, Michael D; Ukairo, Okechukwu; Moore, Amanda; Irrechukwu, Onyi; Potter, David M; Schneider, Richard P.
Afiliación
  • Aleo MD; Drug Safety Research and Development, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut.
  • Ukairo O; BioIVT, formerly Hepregen Corporation, Medford, Massachusetts.
  • Moore A; BioIVT, formerly Hepregen Corporation, Medford, Massachusetts.
  • Irrechukwu O; BioIVT, formerly Hepregen Corporation, Medford, Massachusetts.
  • Potter DM; Drug Safety Research and Development, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut.
  • Schneider RP; Pharmacokinetics, Dynamics and Metabolism, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut.
J Appl Toxicol ; 39(8): 1192-1207, 2019 08.
Article en En | MEDLINE | ID: mdl-31134659
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ácido Taurocólico / Receptores de Endotelina / Hepatocitos / Antagonistas de los Receptores de Endotelina / Hígado / Modelos Biológicos Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Appl Toxicol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ácido Taurocólico / Receptores de Endotelina / Hepatocitos / Antagonistas de los Receptores de Endotelina / Hígado / Modelos Biológicos Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Appl Toxicol Año: 2019 Tipo del documento: Article